Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
23
Views
15
CrossRef citations to date
0
Altmetric
Research Article

The Prognostic Significance of Trisomy 8 in Patients With Acute Myeloid Leukemia

Michelle A. Elliott Division of Hematology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
,
Louis Letendre Division of Hematology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
,
Curtis A. Hanson Division of Hematopathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
,
Ayalew Tefferi Division of Hematology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
&
Gordon W. Dewald Laboratory Genetics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Pages 583-586 | Published online: 01 Jul 2009

  • Mrozek, K., Heinonen, K., de la Chapelle, A. and Bloomfield, C.D. (1997) "Clinical significance of cytogenetics in acute myeloid leukemia", Seminars in Oncology 24, 17-31.
  • Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hano, I., Stevens, R., Burnett, A. and Goldstone, A. (1998) "The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia working parties", Blood 92, 2322-2333.
  • Bloomfield, C.D., Lawrence, D., Byrd, J.C., Carroll, A., Pettenati, M.J., Tantravahi, R., Patil, S.R., Davey, F.R., Berg, D.T., Schiffer, C.A., Arthur, D.C. and Mayer, R.J. (1998) "Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype", Cancer Research 58, 4173-4179.
  • Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., MacIntyre, O.R. and Frei, III, E. (1994) "Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B", The New England Journal of Medicine 331, 896-903.
  • Dastugue, N., Payen, C., Lafage-Pochitaloff, M., Bernard, P., Leroux, D., Huguet-Rigal, F., Stoppa, A.M., Marit, G., Molina, L., Michallet, M., Maraninchi, D., Attal, M. and Reiffers, J. (1995) "Prognostic significance of karyotype in de nova adult acute myeloid leukemia. The BGMT group", Leukemia 9, 1491-1498.
  • German AML Cooperative Study Group: Schoch, C., Haferlach, T., Haase, D., Fonatsch, C., Loffler, H., Schlegelberger, B., Staib, P., Sauerland, M.C., Heinecke, A, Buchner, T. and Hiddemann, W. (2001) "Patients with de nova acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients", British Journal of Haematology 112, 118-126.
  • Berger, R., Bernheim, A., Ochoa-Noguera, M.E., Daniel, M.T., Valensi, F., Signaux, F., Flandrin, G. and Boiron, M. (1987) "Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients", Cancer Genetics and Cytogenetics 28, 293-299.
  • Stasi, R, Del Poeta, G., Masi, M., Tribalto, M., Vendilti, A., Papa, G., Nicoletti, B., Vernole, P., Tedeschi, B., Delaroche, I., Mingarelli, R. and Dallapiccola, B. (1993) "Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia", Cancer Genetics and Cytogenetics 67, 28-34.
  • Schoch, C., Haase, D., Fonatsch, C., Haferlach, T., Loffler, H., Schlegelberger, B., Hossfeld, D.K., Becher, R., Sauerland, M.C., Heinecke, A., Wormann, B., Buchner, T. and Hiddemann, W. (1997) "The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group", British Journal of Haematology 99, 605-611.
  • Byrd, J.C., Lawrence, D., Arthur, D.C., Pettenati, M.J., Tantravahi, R., Qumsiyeh, M., Stamberg, J., Davey, F.R., Schiffer, C.A. and Bloomfield, C.D. (1998) "Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461", Clinical Cancer Research 4, 1235-1241.
  • European APL Group: De Botton, S., Chevret, S., Sanz., M., Dombret, H., Thomas, X., Guerci, A., Fey, M., Rayon, C., Huguet, F., Sotto, JJ., Gardin, C., Cony Makhoul, P., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., San Miguel, J., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Geiser, K., Hess, U., Maloisel, F., Castaigne, S., Preudhomme, C., Chomienne, C., Degos, L. and Fenaux, P. (2000) "Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial", British Journal of Haematology 111, 801-806.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.